1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsLeveraging New Approach Methodologies and Non-Animal Technologies to Accelerate Osteoarthritis Research is sponsored by NIAMS. Invites research grant applications that utilize NAMs and NATs to investigate biological mechanisms driving osteoarthritis.
Get alerted about grants like this
Get emailed when new opportunities from “NIAMS” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Universities, hospitals, medical schools, and other organizations. Confirm the full requirements in the official notice before applying.
Applications for Leveraging New Approach Methodologies and Non-Animal Technologies to Accelerate Osteoarthritis Research are due August 29, 2027. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Leveraging New Approach Methodologies and Non-Animal Technologies to Accelerate Osteoarthritis Research is funded by NIAMS. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Leveraging and Accelerating the Progress Achieved in the Restoring Joint Health and Function to Reduce Pain (RE-JOIN) Consortium (Forecast) is sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). This forecasted NOFO aims to expand upon the achievements of the Restoring Joint Health and Function to Reduce Pain (RE-JOIN) Consortium, a part of the NIH Helping to End Addiction Long Term (HEAL) initiative.
Supporting Research Using the Resources from the Osteoarthritis Initiative (OAI) is sponsored by National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). This funding opportunity invites research grant applications focused on utilizing the Osteoarthritis Initiative (OAI) database, clinical data, and images. Research topics of interest include the use of biospecimens to discover biochemical markers for early or progressive disease, and the investigation of MRI features as predictors of radiographic or clinical OA outcomes. It also encourages the development of robust, reproducible tools for automated image analysis (MRI, X-ray) for OA diagnosis and monitoring.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Innovation Grant is a grant from the Delta Dental of Arizona Foundation that funds nonprofit organizations pursuing unique, high-impact projects that improve health and wellness in Arizona communities. This two-year award supports original initiatives with measurable real-world impact, including programs serving underserved and uninsured populations through oral health education, disease prevention, and nutritional access. Projects must demonstrate the potential to make a meaningful difference in the community and stand apart from conventional approaches. Eligible applicants are Arizona-based nonprofit organizations. Awards total $100,000 per recipient over two years. The 2026 application cycle closed October 16, 2025, with recipients notified in late 2025 and funding made available shortly after.